Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial - Combe, B; Kivitz, A; Tanaka, Y (Ann Rheum Dis, 2021)
et al.